Search over 3,000 reports

    Opioid-Induced Constipation - Epidemiology Forecast to 2025

    Opioid-Induced Constipation - Epidemiology Forecast to 2025
    Date: Dec, 2017
    Type: Pharmaceutical Industry Report
    Pages: 40
    Geography: Global
    Delivery Timeline: 5-7 Business Days
    SKU: DIEI0157
    DelveInsight's "Opioid-Induced Constipation -Epidemiology Forecast, 2025" provides an overview of the epidemiology trends of Opioid-Induced Constipation in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Opioid-Induced Constipation. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Opioid-Induced Constipation. The report contains the targeted patient populations and the forecast methodology.

    The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.

    Key Coverage and Benefits

    • The Report includes the prevalent population and how will it change over the next eight years.
    • Coverage of key Opioid-Induced Constipation sub-populations and its prevalent or incident cases
    • Prevalent or incident cases segmented by age and sex.
    • The key differences in epidemiology patterns across the seven market segments.

    Reasons to buy
    • Developing business strategies by understanding the trends shaping and driving the global Opioid-Induced Constipation market.
    • Identifying prevalent patient populations as well as risk factors in the global Opioid-Induced Constipation market will help to improve product design, pricing, and launch plans.
    • Organize sales and marketing efforts by identifying the best opportunities for Opioid-Induced Constipation therapeutics in each of the markets covered.

    1. Report Introduction
    2. Snapshot of Total Prevalent or Incident cases by 7 MM
    3. Executive Summary
    • Key Findings
    4. Opioid Induced Constipation Overview
    • Opioid Induced Constipation Definition
    • Pathophysiology
    • Symptoms
    • Etiology
    5. Risk Factors Associated with Opioid Induced Constipation
    6. Disease Burden & Unmet Need in the Market
    7. Epidemiology and Patient Populations
    • Key Findings
    • Key Sources used and Forecast Methodology
    • Prevalent Cases and Incident Cases-2015-2025
    • Prevalent & Incident Cases by Category-2015-2025
    • Age-Specific Prevalent/ Incident Cases of Opioid Induced Constipation
    • Sex-Specific Prevalent/Incident Cases of Opioid Induced Constipation
    • Disease Type Specific Prevalent/Incident Cases of Opioid Induced Constipation
    8.Prevalent & Incident Cases by 7 MM-2015-2025
    • Opioid Induced Constipation Epidemiology of United States-2025
    • Opioid Induced Constipation Epidemiology of United Kingdom-2025
    • Opioid Induced Constipation Epidemiology of Germany-2025
    • Opioid Induced Constipation Epidemiology of France-2025
    • Opioid Induced Constipation Epidemiology of Spain-2025
    • Opioid Induced Constipation Epidemiology of Italy-2025
    • Opioid Induced Constipation Epidemiology of Japan-2025
    9. Key Takeaways
    10. Appendix
    11.Report Methodology
    12. Consulting Services
    13. Disclaimer
    14. About Us
    Table 1: Clinical subtypes of Indication
    Table 2: Risk Factors
    Table 3: Prevalence cases (%) Region wise
    Table 4: Sources used for forecasting the data
    Table 5: Opioid-Induced Constipation Global Epidemiology, (2015-2025)
    Table 6: Prevalent Cases of Opioid-Induced Constipation (Ages =XX Years), US (2015-2025)
    Table 7: Prevalent Cases of Opioid-Induced Constipation By Sex (Males & Females), US (2015-2025)
    Table 8: Prevalent Cases By Opioid-Induced Constipation Sub-population, US (2015-2025)
    Table 9: Prevalent Cases of Opioid-Induced Constipation (Ages =XX Years), United Kingdom (2015-2025)
    Table 10: Prevalent Cases of Opioid-Induced Constipation By Sex (Males & Females), United Kingdom (2015-2025)
    Table 11: Prevalent Cases By Opioid-Induced Constipation Sub-population, United Kingdom (2015-2025)
    Table 12: Prevalent Cases of Opioid-Induced Constipation (Ages =XX Years), Germany (2015-2025)
    Table 13: Prevalent Cases of Opioid-Induced Constipation By Sex (Males & Females), Germany (2015-2025)
    Table 14: Prevalent Cases By Opioid-Induced Constipation Sub-population, Germany (2015-2025)
    Table 15: Prevalent Cases of Opioid-Induced Constipation (Ages =XX Years), France (2015-2025)
    Table 16: Prevalent Cases of Opioid-Induced Constipation By Sex (Males & Females), France (2015-2025)
    Table 17: Prevalent Cases By Opioid-Induced Constipation Sub-population, France (2015-2025)
    Table 18: Prevalent Cases of Opioid-Induced Constipation (Ages =XX Years), Italy (2015-2025)
    Table 19: Prevalent Cases of Opioid-Induced Constipation By Sex (Males & Females), Italy (2015-2025)
    Table 20: Prevalent Cases By Opioid-Induced Constipation Sub-population, Italy (2015-2025)
    Table 21: Prevalent Cases of Opioid-Induced Constipation (Ages =XX Years), Spain (2015-2025)
    Table 22: Prevalent Cases of Opioid-Induced Constipation By Sex (Males & Females), Spain (2015-2025)
    Table 23: Prevalent Cases By Opioid-Induced Constipation Sub-population, Spain (2015-2025)
    Table 24: Prevalent Cases of Opioid-Induced Constipation (Ages =XX Years), Japan (2015-2025)
    Table 25: Prevalent Cases of Opioid-Induced Constipation By Sex (Males & Females), Japan (2015-2025)
    Table 26: Prevalent Cases By Opioid-Induced Constipation Sub-population, Japan (2015-2025)
    Figure 1: Prevalence cases (%) Region wise
    Figure 2: Sources used for forecasting the data
    Figure 3: Opioid-Induced Constipation Global Epidemiology, (2015-2025)
    Figure 4: Prevalent Cases of Opioid-Induced Constipation (Ages =XX Years), US (2015-2025)
    Figure 5: Prevalent Cases of Opioid-Induced Constipation By Sex (Males & Females), US (2015-2025)
    Figure 6: Prevalent Cases By Opioid-Induced Constipation Sub-population,US (2015-2025)
    Figure 7: Prevalent Cases of Opioid-Induced Constipation (Ages =XX Years), United Kingdom (2015-2025)
    Figure 8: Prevalent Cases of Opioid-Induced Constipation By Sex (Males & Females), United Kingdom (2015-2025)
    Figure 9: Prevalent Cases By Opioid-Induced Constipation Sub-population,United Kingdom (2015-2025)
    Figure 10: Prevalent Cases of Opioid-Induced Constipation (Ages =XX Years), Germany (2015-2025)
    Figure 11: Prevalent Cases of Opioid-Induced Constipation By Sex (Males & Females), Germany (2015-2025)
    Figure 12: Prevalent Cases By Opioid-Induced Constipation Sub-population,Germany (2015-2025)
    Figure 13: Prevalent Cases of Opioid-Induced Constipation (Ages =XX Years), France (2015-2025)
    Figure 14: Prevalent Cases of Opioid-Induced Constipation By Sex (Males & Females), France (2015-2025)
    Figure 15: Prevalent Cases By Opioid-Induced Constipation Sub-population,France (2015-2025)
    Figure 16: Prevalent Cases of Opioid-Induced Constipation (Ages =XX Years), Italy (2015-2025)
    Figure 17: Prevalent Cases of Opioid-Induced Constipation By Sex (Males & Females), Italy (2015-2025)
    Figure 18: Prevalent Cases By Opioid-Induced Constipation Sub-population,Italy (2015-2025)
    Figure 19: Prevalent Cases of Opioid-Induced Constipation (Ages =XX Years), Spain (2015-2025)
    Figure 20: Prevalent Cases of Opioid-Induced Constipation By Sex (Males & Females), Spain (2015-2025)
    Figure 21: Prevalent Cases By Opioid-Induced Constipation Sub-population,Spain (2015-2025)
    Figure 22: Prevalent Cases of Opioid-Induced Constipation (Ages =XX Years), Japan (2015-2025)
    Figure 23: Prevalent Cases of Opioid-Induced Constipation By Sex (Males & Females), Japan (2015-2025)
    Figure 24: Prevalent Cases By Opioid-Induced Constipation Sub-population,Japan (2015-2025)
    Opioid-Induced Constipation Disease Overview

    Opioid-Induced Constipation Prevalence

    Opioid-Induced Constipation Incidence

    Opioid-Induced Constipation Risk Factors

    Opioid-Induced Constipation Epidemiology

    Opioid-Induced Constipation Patient Populations

    Opioid-Induced Constipation Diagnosed Patients

    Opioid-Induced Constipation Forecast

    Opioid-Induced Constipation Epidemiology Forecast

    Opioid-Induced Constipation Treated patients/population

    • Single User License
      (20% Off)
      $2,950.00
    • Site License
      (30% Off)
      $5,900.00
    • Global License
      (40% Off)
      $8,850.00

    Contact Us

    Phone
    +91-11-45689769, +91 9650213330

    Email
    info@delveinsight.com

    Address
    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap